Ledger.Open graph →
SEC Form D · Amendment · filed June 6, 2025

Iyuda Therapeutics, Inc

Offering
$1.3M
Sold
$1.3M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Owings Mills, MD
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Robert Tennant · Owings Mills, MDExecEphraim Fuchs · Owings Mills, MDDirectorRobert Tennant · Owings Mills, MDExecEphraim Fuchs · Owings Mills, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗